About Objective Biotechnology
Objective Biotechnology is a private company based in Minneapolis, Minnesota, incorporated in 2023 in Delaware. It has reported $714,984 raised in one offering on Form D since November 2024. Its chief executive is James Grabau.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Nov 20, 2024 | Nov 26, 2024 | $714,984of $1.0M target | 11 | $64,999 | EquityRule 506(b) | Form D ↗ |
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Objective Biotechnology's Form D filed Nov 26, 2024.
JG
James Grabau
CEO
DS
Daniel Surinach
Executive officer and director
AJ
Amey Joshi
Executive officer and director
SK
Suhasa Kodandaramaiah
Executive officer and director
AA
Andrew Alegria
Executive officer and director
DG
Daryl Gohl
Executive officer and director